Jen-Tsung Chen is a Professor of Cell Biology at the National University of Kaohsiung in Taiwan, where he teaches cell biology, genomics, proteomics, plant physiology, and plant biotechnology. His research spans bioactive compounds, chromatography techniques, plant molecular biology, bioinformatics, systems pharmacology, and broader themes in biotechnological plant disease management, plant biotic stress responses, nanotechnology for combating pests and pathogens, ethnopharmacology, and systems biology. An active scholar, Dr. Chen serves on the editorial boards of several international journals and has guest‑edited numerous special issues. He has also authored and edited books with major international publishers on topics including drug discovery, herbal medicine, medicinal biotechnology, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, CRISPR‑based genome editing, and artificial intelligence. Recognized for his scientific impact and editorial leadership, Dr. Chen was listed among Elsevier and Stanford University’s “World’s Top 2% Scientists” in 2023 and 2024 and received the Springer Nature Editor of Distinction Award in 2025.

• 1. A comprehensive review of epidemiology, virology, and prevention for COVID-19 and its variants2. Coronavirus Disease 2019 and the SARS-CoV-2 variants: Virological perspectives3. Introduction to antiviral nanomaterials: Mechanisms and applications4. An overview of antiviral nanomedicine: Types, structures and functions5. Nanotechnology-based strategies for combating coronavirus6. Nanotechnology for diagnosis of COVID-19: Current achievements and future directions7. Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants: Recent finding, limitations, and prospects8. The development of lipid nanoparticle technology for the management of COVID-199. Nanotechnology for the prevention of SARS-CoV-2 infection10. Nanotechnology-assisted therapeutic antibodies against SARS-CoV-2 variants: Current findings and future perspectives11. COVID-19 drug delivery: Current achievements and the impact of nanocarriers12. Nanotechnology-based drug delivery for combating SARS-CoV-2 variants13. An overview of COVID-19 vaccine development: Highlighting the role of nanotechnology14. Nanotechnology-based vaccine development for COVID-1915. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID-19 management16. Anti-SARS-CoV-2 nanoparticles: Mechanisms and applications17. Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-218. Nature’s arsenal: Combatting SARS-CoV-2 variants with phytocompound nanoparticles19. Emerging nanomaterials for COVID-19 therapeutics20. Metallic nanoparticles-based strategies for COVID-19 management in the post-pandemic era21.. Nanotechnological Approaches for COVID-19 Management: Highlighting the Impact on SARS-Co-V-2 Variants22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID-19 and Other Infectious Diseases

Jen-Tsung Chen is a Professor of Cell Biology at the National University of Kaohsiung in Taiwan, where he teaches cell biology, genomics, proteomics, plant physiology, and plant biotechnology. His research spans bioactive compounds, chromatography techniques, plant molecular biology, bioinformatics, systems pharmacology, and broader themes in biotechnological plant disease management, plant biotic stress responses, nanotechnology for combating pests and pathogens, ethnopharmacology, and systems biology. An active scholar, Dr. Chen serves on the editorial boards of several international journals and has guest‑edited numerous special issues. He has also authored and edited books with major international publishers on topics including drug discovery, herbal medicine, medicinal biotechnology, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, CRISPR‑based genome editing, and artificial intelligence. Recognized for his scientific impact and editorial leadership, Dr. Chen was listed among Elsevier and Stanford University’s “World’s Top 2% Scientists” in 2023 and 2024 and received the Springer Nature Editor of Distinction Award in 2025.

• 1. A comprehensive review of epidemiology, virology, and prevention for COVID-19 and its variants2. Coronavirus Disease 2019 and the SARS-CoV-2 variants: Virological perspectives3. Introduction to antiviral nanomaterials: Mechanisms and applications4. An overview of antiviral nanomedicine: Types, structures and functions5. Nanotechnology-based strategies for combating coronavirus6. Nanotechnology for diagnosis of COVID-19: Current achievements and future directions7. Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants: Recent finding, limitations, and prospects8. The development of lipid nanoparticle technology for the management of COVID-199. Nanotechnology for the prevention of SARS-CoV-2 infection10. Nanotechnology-assisted therapeutic antibodies against SARS-CoV-2 variants: Current findings and future perspectives11. COVID-19 drug delivery: Current achievements and the impact of nanocarriers12. Nanotechnology-based drug delivery for combating SARS-CoV-2 variants13. An overview of COVID-19 vaccine development: Highlighting the role of nanotechnology14. Nanotechnology-based vaccine development for COVID-1915. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID-19 management16. Anti-SARS-CoV-2 nanoparticles: Mechanisms and applications17. Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-218. Nature’s arsenal: Combatting SARS-CoV-2 variants with phytocompound nanoparticles19. Emerging nanomaterials for COVID-19 therapeutics20. Metallic nanoparticles-based strategies for COVID-19 management in the post-pandemic era21.. Nanotechnological Approaches for COVID-19 Management: Highlighting the Impact on SARS-Co-V-2 Variants22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID-19 and Other Infectious Diseases